135 related articles for article (PubMed ID: 26991004)
1. Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations.
Janssen JA; Hofland LJ; Strasburger CJ; van den Dungen ES; Thevis M
PLoS One; 2016; 11(3):e0150453. PubMed ID: 26991004
[TBL] [Abstract][Full Text] [Related]
2. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA
Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
Neely EK; Rosenfeld RG
Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
[TBL] [Abstract][Full Text] [Related]
4. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
Perdue JF; LeBon TR; Kato J; Hampton B; Fujita-Yamaguchi Y
Endocrinology; 1991 Dec; 129(6):3101-8. PubMed ID: 1659523
[TBL] [Abstract][Full Text] [Related]
5. Mechano-growth factor peptide, the COOH terminus of unprocessed insulin-like growth factor 1, has no apparent effect on myoblasts or primary muscle stem cells.
Fornaro M; Hinken AC; Needle S; Hu E; Trendelenburg AU; Mayer A; Rosenstiel A; Chang C; Meier V; Billin AN; Becherer JD; Brace AD; Evans WJ; Glass DJ; Russell AJ
Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E150-6. PubMed ID: 24253050
[TBL] [Abstract][Full Text] [Related]
6. Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.
Henderson ST; Brierley GV; Surinya KH; Priebe IK; Catcheside DE; Wallace JC; Forbes BE; Cosgrove LJ
Growth Horm IGF Res; 2015 Feb; 25(1):20-7. PubMed ID: 25458127
[TBL] [Abstract][Full Text] [Related]
7. Insulin and insulin-like growth factor I regulate the same biological functions in HEP-G2 cells via their own specific receptors.
Verspohl EJ; Maddux BA; Goldfine ID
J Clin Endocrinol Metab; 1988 Jul; 67(1):169-74. PubMed ID: 2837499
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric characterization of a biotechnologically produced full-length mechano growth factor (MGF) relevant for doping controls.
Thevis M; Thomas A; Geyer H; Schänzer W
Growth Horm IGF Res; 2014 Dec; 24(6):276-80. PubMed ID: 25466910
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells.
Besset V; Le Magueresse-Battistoni B; Collette J; Benahmed M
Endocrinology; 1996 Jan; 137(1):296-303. PubMed ID: 8536626
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: interaction with the IGF-I receptor and IGF-binding proteins.
Weber MM; Simmler P; Fottner C; Engelhardt D
Endocrinology; 1995 Sep; 136(9):3714-20. PubMed ID: 7544271
[TBL] [Abstract][Full Text] [Related]
11. The type II insulin-like growth factor receptor does not mediate deoxyribonucleic acid synthesis in human fibroblasts.
Furlanetto RW; DiCarlo JN; Wisehart C
J Clin Endocrinol Metab; 1987 Jun; 64(6):1142-9. PubMed ID: 2952664
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
13. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
14. Effects of dietary supplementation with cysteamine on growth hormone receptor and insulin-like growth factor system in finishing pigs.
Liu G; Wei Y; Wang Z; Wu D; Zhou A
J Agric Food Chem; 2008 Jul; 56(13):5422-7. PubMed ID: 18553891
[TBL] [Abstract][Full Text] [Related]
15. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells.
Armakolas A; Philippou A; Panteleakou Z; Nezos A; Sourla A; Petraki C; Koutsilieris M
Prostate; 2010 Aug; 70(11):1233-42. PubMed ID: 20564425
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
Ricort JM; Binoux M
Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
[TBL] [Abstract][Full Text] [Related]
17. A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding.
Chrudinová M; Žáková L; Marek A; Socha O; Buděšínský M; Hubálek M; Pícha J; Macháčková K; Jiráček J; Selicharová I
J Biol Chem; 2018 Oct; 293(43):16818-16829. PubMed ID: 30213860
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
Chisalita SI; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
[TBL] [Abstract][Full Text] [Related]
19. A strong neuroprotective effect of the autonomous C-terminal peptide of IGF-1 Ec (MGF) in brain ischemia.
Dluzniewska J; Sarnowska A; Beresewicz M; Johnson I; Srai SK; Ramesh B; Goldspink G; Górecki DC; Zabłocka B
FASEB J; 2005 Nov; 19(13):1896-8. PubMed ID: 16144956
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity.
Costantino A; Vinci C; Mineo R; Frasca F; Pandini G; Milazzo G; Vigneri R; Belfiore A
Endocrinology; 1996 Oct; 137(10):4100-7. PubMed ID: 8828463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
